Phathom Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 12 analysts polled by S&P Global, Phathom Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $20.45. The average 1-year stock price forecast is 173.40% higher than the current stock price, while the lowest is $10 (+33.69%) and the highest is $29 (+287.70%).

Price Target: $20.45 (+173.40%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$10	$20.45	$21	$29
Change	+33.69%	+173.40%	+180.75%	+287.70%

Analyst Ratings

The average analyst rating for Phathom Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Apr '26	May '26	Jun '26	Jul '26	Aug '26	Sep '26
Strong Buy	7	7	7	8	8	8
Buy	2	2	2	2	2	2
Hold	1	1	1	1	1	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	10	10	11	11	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Daniel Clark Leerink Partners	Leerink Partners	Hold Initiates $10	Hold	Initiates	$10	+33.69%	Sep 9, 2026
Jenna Davidner Barclays	Barclays	Buy Maintains $14	Buy	Maintains	$14	+87.17%	Aug 17, 2026
Chase Knickerbocker Craig-Hallum	Craig-Hallum	Buy Reiterates $22 → $20	Buy	Reiterates	$22 → $20	+167.38%	Jul 31, 2026
Martin Auster Raymond James	Raymond James	Buy Maintains $21	Buy	Maintains	$21	+180.75%	Jul 31, 2026
Yatin Suneja Guggenheim	Guggenheim	Buy Maintains $25 → $22	Buy	Maintains	$25 → $22	+194.12%	Jul 31, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

316.07M

from 175.11M

80.50%

from 175.11M

Revenue Next Year

495.10M

from 316.07M

56.64%

from 316.07M

EPS This Year

-0.03

from -2.06

EPS Next Year

1.08

from -0.03

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	682.00K	55.25M	175.11M	316.07M
Revenue Growth	-	-	-	8,001.47%	216.93%	80.50%
Gross Profit	-	-	515.00K	47.28M	152.51M	252.70M
Gross Margin	-	-	75.51%	85.57%	87.09%	79.95%
Operating Income	-135.08M	-172.44M	-167.31M	-277.47M	-159.99M	-2.99M
Net Income	-143.88M	-197.72M	-201.59M	-334.33M	-221.25M	-64.86M
EPS	-	-	-	-	-2.06	-0.03
Free Cash Flow	-	-	-	-	-107.86M	-51.40M
No. Analysts	-	-	-	-	-	10

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	323.1M
Avg	316.1M
Low	311.9M

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	84.5%
Avg	80.5%
Low	78.1%

EPS Forecast

Chart

EPS	2026	2027	2028
High	0.04
Avg	-0.03
Low	-0.11

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-